147 related articles for article (PubMed ID: 24047257)
1. Pharmacophore-based discovery of new human dihydroorotate dehydrogenase inhibitor.
Lu P; Wang Y; Ma B; She J; Zhang Q; He M; Liu Y
Med Chem; 2014 Jun; 10(4):402-8. PubMed ID: 24047257
[TBL] [Abstract][Full Text] [Related]
2. Natural products as inhibitors of Leishmania major dihydroorotate dehydrogenase.
Chibli LA; Schmidt TJ; Nonato MC; Calil FA; Da Costa FB
Eur J Med Chem; 2018 Sep; 157():852-866. PubMed ID: 30145372
[TBL] [Abstract][Full Text] [Related]
3. Understanding the structural requirements in diverse scaffolds for the inhibition of P. falciparum dihydroorotate dehydrogenase (PfDHODH) using 2D-QSAR, 3D-pharmacophore and structure-based energy- optimized pharmacophore models.
Aher RB; Roy K
Comb Chem High Throughput Screen; 2015; 18(2):217-26. PubMed ID: 25543684
[TBL] [Abstract][Full Text] [Related]
4. [Design, synthesis and structure-activity relationship studies of human dihydroorotate dehydrogenase inhibitors].
Gong YH; Liu L; Qi TT; Li HL; Zhu LL; Zhao ZJ
Yao Xue Xue Bao; 2017 Feb; 52(2):264-70. PubMed ID: 29979514
[TBL] [Abstract][Full Text] [Related]
5. Plasmodium falciparum dihydroorotate dehydrogenase: a drug target against malaria.
Hoelz LV; Calil FA; Nonato MC; Pinheiro LC; Boechat N
Future Med Chem; 2018 Aug; 10(15):1853-1874. PubMed ID: 30019917
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, Design, and Structure⁻Activity Relationship of the Pyrimidone Derivatives as Novel Selective Inhibitors of
Xu L; Li W; Diao Y; Sun H; Li H; Zhu L; Zhou H; Zhao Z
Molecules; 2018 May; 23(6):. PubMed ID: 29794978
[TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR Based Pharmacophore Modeling and Virtual Screening for Identification of Novel G Protein-Coupled Receptor40 Agonists.
Lu P; Wang Y; Ouyang P; She J; He M
Curr Comput Aided Drug Des; 2015; 11(1):51-6. PubMed ID: 26022066
[TBL] [Abstract][Full Text] [Related]
8. Identification of New Human Malaria Parasite Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors by Pharmacophore and Structure-Based Virtual Screening.
Pavadai E; El Mazouni F; Wittlin S; de Kock C; Phillips MA; Chibale K
J Chem Inf Model; 2016 Mar; 56(3):548-62. PubMed ID: 26915022
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, X-ray crystallographic analysis, and biological evaluation of thiazole derivatives as potent and selective inhibitors of human dihydroorotate dehydrogenase.
Zhu J; Han L; Diao Y; Ren X; Xu M; Xu L; Li S; Li Q; Dong D; Huang J; Liu X; Zhao Z; Wang R; Zhu L; Xu Y; Qian X; Li H
J Med Chem; 2015 Feb; 58(3):1123-39. PubMed ID: 25580811
[TBL] [Abstract][Full Text] [Related]
10. E-pharmacophore and molecular dynamics study of flavonols and dihydroflavonols as inhibitors against dihydroorotate dehydrogenase.
Swaminathan P; Kalva S; Saleena LM
Comb Chem High Throughput Screen; 2014; 17(8):663-73. PubMed ID: 24655039
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a novel series of hDHODH inhibitors with anti-pulmonary fibrotic activities.
Lu K; Zhao Y; Wu G; Hu H; Wang M; Gong G; Jiang Y
Bioorg Chem; 2019 May; 86():44-51. PubMed ID: 30685643
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and pharmacological evaluation of novel substituted quinoline-2-carboxamide derivatives as human dihydroorotate dehydrogenase (hDHODH) inhibitors and anticancer agents.
Vyas VK; Variya B; Ghate MD
Eur J Med Chem; 2014 Jul; 82():385-93. PubMed ID: 24929289
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Biological Evaluation of 4-Quinoline Carboxylic Acids as Inhibitors of Dihydroorotate Dehydrogenase.
Madak JT; Cuthbertson CR; Miyata Y; Tamura S; Petrunak EM; Stuckey JA; Han Y; He M; Sun D; Showalter HD; Neamati N
J Med Chem; 2018 Jun; 61(12):5162-5186. PubMed ID: 29727569
[TBL] [Abstract][Full Text] [Related]
14. Factors influencing the specificity of inhibitor binding to the human and malaria parasite dihydroorotate dehydrogenases.
Bedingfield PT; Cowen D; Acklam P; Cunningham F; Parsons MR; McConkey GA; Fishwick CW; Johnson AP
J Med Chem; 2012 Jun; 55(12):5841-50. PubMed ID: 22621375
[TBL] [Abstract][Full Text] [Related]
15. Comparative study between 3D-QSAR and Docking-Based Pharmacophore models for potent Plasomodium falciparum dihydroorotate dehydrogenase inhibitors.
Tseng TS; Lee YC; Hsiao NW; Liu YR; Tsai KC
Bioorg Med Chem Lett; 2016 Jan; 26(2):265-271. PubMed ID: 26707392
[TBL] [Abstract][Full Text] [Related]
16. Novel insights for dihydroorotate dehydrogenase class 1A inhibitors discovery.
Cheleski J; Rocha JR; Pinheiro MP; Wiggers HJ; da Silva AB; Nonato MC; Montanari CA
Eur J Med Chem; 2010 Dec; 45(12):5899-909. PubMed ID: 20965617
[TBL] [Abstract][Full Text] [Related]
17. Novel Diketopiperazine Dihydroorotate Dehydrogenase Inhibitors Purified from Traditional Tibetan Animal Medicine Osteon Myospalacem Baileyi.
Jiang L; Wen H; Shao Y; Yu R; Liu Z; Wang S; Wang Q; Zhao X; Zhang P; Tao Y; Mei L
Chem Biol Drug Des; 2015 Oct; 86(4):626-36. PubMed ID: 25626527
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel PfDHODH inhibitors as antimalarial agents via pharmacophore-based virtual screening followed by molecular docking and in vivo antimalarial activity.
Vyas VK; Qureshi G; Ghate M; Patel H; Dalai S
SAR QSAR Environ Res; 2016 Jun; 27(6):427-40. PubMed ID: 27310104
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a new class of potent pyrrolo[3,4-c]quinoline-1,3-diones based inhibitors of human dihydroorotate dehydrogenase: Synthesis, pharmacological and toxicological evaluation.
Dimitrijević MG; Roschger C; Lang K; Zierer A; Paunović MG; Obradović AD; Matić MM; Pocrnić M; Galić N; Ćirić A; Joksović MD
Bioorg Chem; 2024 Jun; 147():107359. PubMed ID: 38613925
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of beta-hydroxy-propenamide derivatives and the inhibition of human dihydroorotate dehydrogenase.
Kim TH; Na HS; Löffler M
Arch Pharm Res; 2003 Mar; 26(3):197-201. PubMed ID: 12723931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]